DonaldLevyMD

PubMed

• 1 citations
  An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy.
  Li, H., Padilla, B., Li-Mcleod, J., Lumry, W., Bernstein, J., Levy, D., Jones, D., Tachdjian, R.> ;Allergy and Asthma Proceedings. 2024 Jan 1
• 22 citations
  Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomise...
  Timothy Craig, Markus Magerl, Donald S Levy, Avner Reshef, William R Lumry, Inmaculada Martinez-Saguer, Joshua S Jacobs, William H Yang, Bruce Ritchie, Emel Aygören-Pü...> ;Lancet. 2022 Mar 5
• Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioed...
  William R Lumry, Bruce Zuraw, Marco Cicardi, Timothy Craig, John Anderson, Aleena Banerji, Jonathan A Bernstein, Teresa Caballero, Henriette Farkas, Richard G Gower, P...> ;Orphanet Journal of Rare Diseases. 2021 Jul 28
• 6 citations
  Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with her...
  John Anderson, Donald Levy, William R. Lumry, Patricia Koochaki, Sally Lanar, H. Henry Li> ;Allergy, Asthma, and Clinical Immunology. 2021 Jun 27
• 6 citations
  Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters
  Avner Reshef, Donald Levy, Hilary Longhurst, Marco Cicardi, Timothy J. Craig, Paul K. Keith, Annette Feussner, Henrike Feuersenger, Thomas Machnig, Subhransu Prusty, I...> ;Thrombosis and Haemostasis. 2021 May 1
• 10 citations
  Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: fi...
  William R Lumry, Bruce Zuraw, Marco Cicardi, Timothy Craig, John Anderson, Aleena Banerji, Jonathan A Bernstein, Teresa Caballero, Henriette Farkas, Richard G Gower, P...> ;Orphanet Journal of Rare Diseases. 2021 Feb 15
• 7 citations
  Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema.
  Donald Levy, Teresa Caballero, I. Hussain, Avner Reshef, John Anderson, James R. Baker, Lawrence B. Schwartz, Marco Cicardi, Subhransu Prusty, Henrike Feuersenger, Ing...> ;Pediatric Allergy, Immunology, and Pulmonology. 2020 Sep 16
• 15 citations
  Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review
  Donald Levy, Timothy J. Craig, Paul K. Keith, Girishanthy Krishnarajah, Rachel Beckerman, Subhransu Prusty> ;Allergy, Asthma, and Clinical Immunology. 2020 May 27
• 4 citations
  Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
  Henriette Farkas, Donald Levy, Dylan Supina, Melvin Berger, Subhransu Prusty, Moshe Fridman> ;Allergy, Asthma, and Clinical Immunology. 2020 May 27
• 1 citations
  Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy.
  William R. Lumry, Teri Templeton, Laurel Omert, Donald Levy> ;Journal of Infusion Nursing. 2020 May 1
• 11 citations
  Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
  Donald Levy, Henriette Farkas, Marc A. Riedl, Florence Ida Hsu, Joel P Brooks, Marco Cicardi, Henrike Feuersenger, Ingo Pragst, Avner Reshef> ;Allergy, Asthma, and Clinical Immunology. 2020 Feb 4
• 10 citations
  Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study
  H. Henry Li, Bruce L. Zuraw, Hilary Longhurst, Marco Cicardi, Konrad Bork, James R. Baker, William R. Lumry, Jonathan A. Bernstein, Michael E. Manning, Donald Levy, Ma...> ;Allergy, Asthma, and Clinical Immunology. 2019 Aug 28
• 54 citations
  Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks
  Timothy J. Craig, Bruce L. Zuraw, Hilary Longhurst, Marco Cicardi, Konrad Bork, Clive Grattan, Constance H. Katelaris, Gordon Sussman, Paul K. Keith, William H. Yang, ...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2019 Jul 1
• 56 citations
  Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema
  William R. Lumry, Timothy J. Craig, Bruce L. Zuraw, Hilary Longhurst, James R. Baker, H. Henry Li, Jonathan A. Bernstein, John Anderson, Marc A. Riedl, Michael E. Mann...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2018 Sep 1
• 120 citations
  Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor
  Hilary Longhurst, Marco Cicardi, Timothy J. Craig, Konrad Bork, Clive Grattan, James R. Baker, H. Li, Avner Reshef, James R. Bonner, Jonathan A. Bernstein, John Anders...> ;The New England Journal of Medicine. 2017 Mar 22
• Flovent (fluticasone propionate inhalation aerosol)
  Donald Levy> ;The Journal of Allergy and Clinical Immunology. 1997 Jun 1
• Join now to see all